The online community for biotechnology industry of Switzerland.

SuisseBio has seen steady growth since 2004 and is expected to continue to expand. The Swiss biopharmaceutical market’s strength lies in the ability to carry products to the final stage of development. Switzerland ranks second in the number of pipelines in all phases according to Ernst & Young. Although Switzerland is a smaller country, its success has placed this Hotbed in the company of the world’s most successful biotechnology markets.

Join the World Discussion Forum

Click here to Search Jobs

Hotbed News
Novartis AG (NVS) Issues New Research Guidelines After Japan Study Scandal Monday, July 28, 2014
Amgen (AMGN) Nervous As FDA Paves Way For Novartis AG (NVS) To Copy Drug Neupogen Monday, July 28, 2014
Novartis AG (NVS), Google Inc. Strike Smart Contact Lenses Pact Monday, July 28, 2014
Novartis AG (NVS) To Test Alzheimer's Drugs In Patients Without Symptoms Monday, July 28, 2014
AstraZeneca PLC (AZN) Taps Roche (RHHBY) For New Blood-Based Cancer Drug Tests Monday, July 28, 2014
Amarantus BioSciences, Inc. Appoints Donald D. Huffman To Board Of Directors Monday, July 28, 2014
Roche (RHHBY) Profit Dented On Diagnostics Writedown Friday, July 25, 2014
Lonza Group Ltd. (LZAGY.PK) Half-Year Business Performance Fully On Track Thursday, July 24, 2014
Commentary: BioSpace (DHX) Readers Sound Off On Big Pharma Takeovers Thursday, July 24, 2014
Novartis AG (NVS) Layoffs Announced: More Cuts May Be Looming Tuesday, July 22, 2014
12345678910